Arne Engelsberg

1.6k total citations
16 papers, 600 citations indexed

About

Arne Engelsberg is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Arne Engelsberg has authored 16 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Molecular Biology. Recurrent topics in Arne Engelsberg's work include Prostate Cancer Treatment and Research (4 papers), PARP inhibition in cancer therapy (4 papers) and Polyomavirus and related diseases (3 papers). Arne Engelsberg is often cited by papers focused on Prostate Cancer Treatment and Research (4 papers), PARP inhibition in cancer therapy (4 papers) and Polyomavirus and related diseases (3 papers). Arne Engelsberg collaborates with scholars based in Germany, United States and France. Arne Engelsberg's co-authors include Barbara Seliger, Armin Rehm, Stefan Störkel, C. Huber, Jean Decker, Elena Neumann, E. Jaeger, Ricardo Hermosilla, Bernd Dörken and Eugene Maraskovsky and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Arne Engelsberg

15 papers receiving 593 citations

Peers

Arne Engelsberg
Tomonori Higuchi Japan
Semjon Willier Germany
Xinyi Tu United States
Lexus R. Johnson United States
Walid Awad United States
Florent Carrette France
Michelle L. Badura United States
Qian Zhu China
Yago Pico de Coaña Sweden
Lennart Ivarsson Austria
Tomonori Higuchi Japan
Arne Engelsberg
Citations per year, relative to Arne Engelsberg Arne Engelsberg (= 1×) peers Tomonori Higuchi

Countries citing papers authored by Arne Engelsberg

Since Specialization
Citations

This map shows the geographic impact of Arne Engelsberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arne Engelsberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arne Engelsberg more than expected).

Fields of papers citing papers by Arne Engelsberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arne Engelsberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arne Engelsberg. The network helps show where Arne Engelsberg may publish in the future.

Co-authorship network of co-authors of Arne Engelsberg

This figure shows the co-authorship network connecting the top 25 collaborators of Arne Engelsberg. A scholar is included among the top collaborators of Arne Engelsberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arne Engelsberg. Arne Engelsberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
3.
Agarwal, Neeraj, Tian Zhang, Eleni Efstathiou, et al.. (2023). The biology behind combining poly [ADP ribose] polymerase and androgen receptor inhibition for metastatic castration-resistant prostate cancer. European Journal of Cancer. 192. 113249–113249. 21 indexed citations
4.
Azad, Arun, Karim Fizazi, Nobuaki Matsubara, et al.. (2023). Talazoparib (TALA) plus enzalutamide (ENZA) in metastatic castration-resistant prostate cancer (mCRPC): Safety analyses from the randomized, placebo (PBO)-controlled, phase 3 TALAPRO-2 study.. Journal of Clinical Oncology. 41(16_suppl). 5053–5053. 5 indexed citations
5.
Walker, John, Célèste Lebbé, Giovanni Grignani, et al.. (2020). Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program. Journal for ImmunoTherapy of Cancer. 8(1). e000313–e000313. 52 indexed citations
6.
Nathan, Paul, Vijay Kasturi, Luc Dirix, et al.. (2018). Avelumab in European patients (pts) with metastatic Merkel cell carcinoma (mMCC): Experience from an ad-hoc expanded access program (EAP). Annals of Oncology. 29. viii460–viii461. 2 indexed citations
7.
Ascierto, Paolo A., Paul Nathan, Luc Dirix, et al.. (2018). Avelumab in European patients (pts) with metastatic Merkel cell carcinoma (mMCC): Experience from an ad hoc expanded access program (EAP). Annals of Oncology. 29. x29–x29. 1 indexed citations
8.
Engelsberg, Arne. (2015). Cross-over—it's a feature, not a bug. Annals of Oncology. 26(9). 2000–2002. 1 indexed citations
9.
Cappuzzo, Federico, Denis Moro‐Sibilot, Oliver Gautschi, et al.. (2014). Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: An expert consensus. Lung Cancer. 87(2). 89–95. 38 indexed citations
10.
Nielsen, Morten S., Peder Madsen, Arne Engelsberg, et al.. (2008). Different Motifs Regulate Trafficking of SorCS1 Isoforms. Traffic. 9(6). 980–994. 34 indexed citations
11.
Engelsberg, Arne, et al.. (2006). The N-terminus of the serum- and glucocorticoid-inducible kinase Sgk1 specifies mitochondrial localization and rapid turnover. Biochemical Journal. 399(1). 69–76. 26 indexed citations
12.
Delgado, Ignacio, Ricardo Hermosilla, Arne Engelsberg, et al.. (2005). EBAG9 Adds a New Layer of Control on Large Dense-Core Vesicle Exocytosis via Interaction with Snapin. Molecular Biology of the Cell. 16(3). 1245–1257. 38 indexed citations
13.
Engelsberg, Arne, Ricardo Hermosilla, Uwe Karsten, et al.. (2003). The Golgi Protein RCAS1 Controls Cell Surface Expression of Tumor-associated O-Linked Glycan Antigens. Journal of Biological Chemistry. 278(25). 22998–23007. 57 indexed citations
14.
Coral, Sandra, Luca Sigalotti, Maresa Altomonte, et al.. (2002). 5-aza-2'-deoxycytidine-induced expression of functional cancer testis antigens in human renal cell carcinoma: immunotherapeutic implications.. PubMed. 8(8). 2690–5. 130 indexed citations
15.
Rehm, Armin, Arne Engelsberg, Domenico Tortorella, et al.. (2002). Human Cytomegalovirus Gene Products US2 and US11 Differ in Their Ability To Attack Major Histocompatibility Class I Heavy Chains in Dendritic Cells. Journal of Virology. 76(10). 5043–5050. 58 indexed citations
16.
Neumann, Elena, Arne Engelsberg, Jean Decker, et al.. (1998). Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies?. PubMed. 58(18). 4090–5. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomonori Higuchi Breakdown of academic impact, for papers by Semjon Willier Breakdown of academic impact, for papers by Xinyi Tu Breakdown of academic impact, for papers by Lexus R. Johnson Breakdown of academic impact, for papers by Walid Awad Breakdown of academic impact, for papers by Florent Carrette Breakdown of academic impact, for papers by Michelle L. Badura Breakdown of academic impact, for papers by Qian Zhu Breakdown of academic impact, for papers by Yago Pico de Coaña Breakdown of academic impact, for papers by Lennart Ivarsson
Rankless by CCL
2026